Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 518 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Daiichi integrates DSPP and DSCP Odawara plants

The integration aims to build a consistent system of manufacturing everything from intermediates to API while utilizing scientific research capabilities to enhance the manufacturing technology infrastructure and make

FDA clears Janssen’s Invokana for type 2 diabetes

Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic control and reduced body weight and systolic blood pressure in clinical trials. Janssen Pharmaceuticals medical

Dr. Reddy’s launches Zenatane in US

The launch follows the FDA approval of the company’s ANDA for Zenatane 10mg, 20mg and 40mg. Zenatane (Isotretinoin Capsules USP) is a generic version, therapeutically equivalent to Accutane

US FDA clears Teva Quartette oral contraceptive NDA

Quartette, designed as next generation of extended regimen oral contraceptives, will reduce breakthrough bleeding (BTB) between scheduled periods. Because of the 91-day oral regimen, an increase in estrogen